PLXDC1 and neoplasm: Furthermore, in nine independent PDAC cohorts comprising 1169 samples, we identified PLXDC1+ TPSCs as unfavorable prognostic markers, with six cohorts showing statistical significance (Figure 3F; Figure S3E,F, Supporting Information), implying their potential involvement in tumor progression.